Avinger Inc (NASDAQ:AVGR) saw a significant growth in short interest in May. As of May 31st, there was short interest totalling 1,412,553 shares, a growth of 119.3% from the May 15th total of 644,042 shares. Based on an average daily volume of 6,297,299 shares, the days-to-cover ratio is currently 0.2 days. Approximately 25.5% of the shares of the stock are short sold.
Separately, LADENBURG THALM/SH SH started coverage on Avinger in a research report on Friday, March 9th. They set a “buy” rating on the stock.
Shares of Avinger stock opened at $1.67 on Friday. Avinger has a 12 month low of $0.95 and a 12 month high of $38.40. The company has a market cap of $9.68 million, a price-to-earnings ratio of -0.02 and a beta of 0.81.
Avinger (NASDAQ:AVGR) last announced its earnings results on Monday, May 14th. The medical device company reported ($5.37) EPS for the quarter, missing analysts’ consensus estimates of ($0.84) by ($4.53). The business had revenue of $1.81 million during the quarter. equities research analysts expect that Avinger will post -6.45 EPS for the current fiscal year.
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.